The DOI matches its Crossref record; 181 of the 181 references it cites were found in a registry or an index.
Beyond TNF: TNF superfamily cytokines as targets for the treatment of rheumatic diseases
Open accessAbstract
TNF blockers are highly efficacious at dampening inflammation and reducing symptoms in rheumatic diseases such as rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis, and also in nonrheumatic syndromes such as inflammatory bowel disease. As TNF belongs to a superfamily of 19 structurally related proteins that have both proinflammatory and anti-inflammatory activity, reagents that disrupt the interaction between proinflammatory TNF family cytokines and their receptors, or agonize the anti-inflammatory receptors, are being considered for the treatment of rheumatic diseases. Biologic agents that block B cell activating factor (BAFF) and receptor activator of nuclear factor-κB ligand (RANKL) have been approved for the treatment of systemic lupus erythematosus and osteoporosis, respectively. In this Review, we focus on additional members of the TNF superfamily that could be relevant for the pathogenesis of rheumatic disease, including those that can strongly promote activity of immune cells or increase activity of tissue cells, as well as those that promote death pathways and might limit inflammation. We examine preclinical mouse and human data linking these molecules to the control of damage in the joints, muscle, bone or other tissues, and discuss their potential as targets for future therapy of rheumatic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The TNF and TNF Receptor Superfamilies
Locksley, R. M., Killeen, N., & Lenardo, M. J. (2001) · Cell · doi:10.1016/s0092-8674(01)00237-9 · Cited by 3,650
Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A., & Nagata, S. (1992) · Nature · doi:10.1038/356314a0 · Cited by 2,885
Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes
Micheau, O., & Tschopp, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00521-x · Cited by 2,738
Lethal effect of the anti-Fas antibody in mice
Ogasawara, J., Watanabe-Fukunaga, R., Adachi, M., Matsuzawa, A., Kasugai, T., Kitamura, Y., Itoh, N., Suda, T., & Nagata, S. (1993) · Nature · doi:10.1038/364806a0 · Cited by 1,881
Furie, R., Petri, M., Zamani, O., Cervera, R., Wallace, D. J., Tegzová, D., Sanchez-Guerrero, J., Schwarting, A., Merrill, J. T., Chatham, W. W., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30613 · Cited by 1,683
Fisher, G. H., Rosenberg, F. J., Straus, S. E., Dale, J. K., Middelton, L. A., Lin, A. Y., Strober, W., Lenardo, M. J., & Puck, J. M. (1995) · Cell · doi:10.1016/0092-8674(95)90013-6 · Cited by 1,465
TNF biology, pathogenic mechanisms and emerging therapeutic strategies
Kalliolias, G. D., & Ivashkiv, L. B. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.169 · Cited by 1,387
TNF/TNFR FAMILY MEMBERS IN COSTIMULATION OF T CELL RESPONSES
Watts, T. H. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115839 · Cited by 1,353
Mutations in Fas Associated with Human Lymphoproliferative Syndrome and Autoimmunity
Rieux-Laucat, F., Le Deist, F., Hivroz, C., Roberts, I. A. G., Debatin, K. M., Fischer, A., & de Villartay, J. P. (1995) · Science · doi:10.1126/science.7539157 · Cited by 1,297
Identity of tumour necrosis factor and the macrophage-secreted factor cachectin
Beutler, B., Greenwald, D., Hulmes, J. D., Chang, M., Pan, Y.-C. E., Mathison, J., Ulevitch, R., & Cerami, A. (1985) · Nature · doi:10.1038/316552a0 · Cited by 1,131
The CD95(APO-1/Fas) DISC and beyond
Peter, M. E., & Krammer, P. H. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401186 · Cited by 1,080
The role of TNF superfamily members in T-cell function and diseases
Croft, M. (2009) · Nature Reviews Immunology · doi:10.1038/nri2526 · Cited by 920
Self-citationThe molecular architecture of the TNF superfamily
Bodmer, J.-L., Schneider, P., & Tschopp, J. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)01995-8 · Cited by 916
Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?
Croft, M. (2003) · Nature Reviews Immunology · doi:10.1038/nri1148 · Cited by 863
Self-citationApo2L/TRAIL and its death and decoy receptors
LeBlanc, H. N., & Ashkenazi, A. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401187 · Cited by 854
CD40 Ligand Gene Defects Responsible for X-Linked Hyper-IgM Syndrome
Allen, R. C., Armitage, R. J., Conley, M. E., Rosenblatt, H., Jenkins, N. A., Copeland, N. G., Bedell, M. A., Edelhoff, S., Disteche, C. M., Simoneaux, D. K., et al. (1993) · Science · doi:10.1126/science.7679801 · Cited by 830
TWEAK, a New Secreted Ligand in the Tumor Necrosis Factor Family That Weakly Induces Apoptosis
Chicheportiche, Y., Bourdon, P. R., Xu, H., Hsu, Y.-M., Scott, H., Hession, C., Garcia, I., & Browning, J. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.51.32401 · Cited by 694
Wang, J., Zheng, L., Lobito, A., Chan, F. K.-M., Dale, J., Sneller, M., Yao, X., Puck, J. M., Straus, S. E., & Lenardo, M. J. (1999) · Cell · doi:10.1016/s0092-8674(00)80605-4 · Cited by 640
CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death
Janssen, E. M., Droin, N. M., Lemmens, E. E., Pinkoski, M. J., Bensinger, S. J., Ehst, B. D., Griffith, T. S., Green, D. R., & Schoenberger, S. P. (2005) · Nature · doi:10.1038/nature03337 · Cited by 619
Boumpas, D. T., Furie, R., Manzi, S., Illei, G. G., Wallace, D. J., Balow, J. E., Vaishnaw, A., & on behalf of the BG9588 Lupus Nephritis Trial Group (2003) · Arthritis & Rheumatism · doi:10.1002/art.10856 · Cited by 618
Biology of the RANKL–RANK–OPG System in Immunity, Bone, and Beyond
Walsh, M. C., & Choi, Y. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00511 · Cited by 599
Anti-TNF therapy: past, present and future
Monaco, C., Nanchahal, J., Taylor, P., & Feldmann, M. (2015) · International Immunology · doi:10.1093/intimm/dxu102 · Cited by 581
Control of Immunity by the TNFR-Related Molecule OX40 (CD134)
Croft, M. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101243 · Cited by 548
Self-citationCommon variants at CD40 and other loci confer risk of rheumatoid arthritis
Raychaudhuri, S., Remmers, E. F., Lee, A. T., Hackett, R., Guiducci, C., Burtt, N. P., Gianniny, L., Korman, B. D., Padyukov, L., Kurreeman, F. A. S., et al. (2008) · Nature Genetics · doi:10.1038/ng.233 · Cited by 535
Genovese, M. C., Cohen, S., Moreland, L., Lium, D., Robbins, S., Newmark, R., Bekker, P., & for the 20000223 Study Group (2004) · Arthritis & Rheumatism · doi:10.1002/art.20221 · Cited by 532
Drappa, J., Vaishnaw, A. K., Sullivan, K. E., Chu, J.-L., & Elkon, K. B. (1996) · New England Journal of Medicine · doi:10.1056/nejm199611283352204 · Cited by 480
Prevention of Collagen-Induced Arthritis with an Antibody to gp39, the Ligand for CD40
Durie, F. H., Fava, R. A., Foy, T. M., Aruffo, A., Ledbetter, J. A., & Noelle, R. J. (1993) · Science · doi:10.1126/science.7689748 · Cited by 457
Clinical targeting of the TNF and TNFR superfamilies
Croft, M., Benedict, C. A., & Ware, C. F. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3930 · Cited by 456
Self-citationThe Role of CD40 Ligand in Costimulation and T‐Cell Activation
Grewal, I. S., & Flavell, R. A. (1996) · Immunological Reviews · doi:10.1111/j.1600-065x.1996.tb00921.x · Cited by 449
The BAFF/APRIL system in SLE pathogenesis
Vincent, F. B., Morand, E. F., Schneider, P., & Mackay, F. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.33 · Cited by 448
A Novel TNF Receptor Family Member Binds TWEAK and Is Implicated in Angiogenesis
Wiley, S. R., Cassiano, L., Lofton, T., Davis-Smith, T., Winkles, J. A., Lindner, V., Liu, H., Daniel, T. O., Smith, C. A., & Fanslow, W. C. (2001) · Immunity · doi:10.1016/s1074-7613(01)00232-1 · Cited by 377
Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis.
Mohan, C., Shi, Y., Laman, J. D., & Datta, S. K. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.3.1470 · Cited by 364
Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL−/− mice
Lamhamedi-Cherradi, S.-E., Zheng, S.-J., Maguschak, K. A., Peschon, J., & Chen, Y. H. (2003) · Nature Immunology · doi:10.1038/ni894 · Cited by 348
Kalunian, K. C., Davis, J. C., Merrill, J. T., Totoritis, M. C., Wofsy, D., & for the IDEC‐131 Lupus Study Group (2002) · Arthritis & Rheumatism · doi:10.1002/art.10681 · Cited by 336
Mariette, X., Seror, R., Quartuccio, L., Baron, G., Salvin, S., Fabris, M., Desmoulins, F., Nocturne, G., Ravaud, P., & De Vita, S. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203991 · Cited by 329
4-1BB-mediated immunotherapy of rheumatoid arthritis
Seo, S. K., Choi, J. H., Kim, Y. H., Kang, W. J., Park, H. Y., Suh, J. H., Choi, B. K., Vinay, D. S., & Kwon, B. S. (2004) · Nature Medicine · doi:10.1038/nm1107 · Cited by 325
Nolte, M. A., Van Olffen, R. W., Van Gisbergen, K. P. J. M., & Van Lier, R. A. W. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00774.x · Cited by 305
Weinblatt, M., Schiff, M., Goldman, A., Kremer, J., Luggen, M., Li, T., Chen, D., & Becker, J.-C. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.055111 · Cited by 300
Eissner, G., Kolch, W., & Scheurich, P. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.03.011 · Cited by 298
Chen, X., Wu, X., Zhou, Q., Howard, O. M. Z., Netea, M. G., & Oppenheim, J. J. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202659 · Cited by 293
Lymphotoxin/LIGHT, lymphoid microenvironments and autoimmune disease
Gommerman, J. L., & Browning, J. L. (2003) · Nature Reviews Immunology · doi:10.1038/nri1151 · Cited by 292
CD40 and autoimmunity: The dark side of a great activator
Peters, A. L., Stunz, L. L., & Bishop, G. A. (2009) · Seminars in Immunology · doi:10.1016/j.smim.2009.05.012 · Cited by 270
Ray, A., Basu, S., Williams, C. B., Salzman, N. H., & Dittel, B. N. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103354 · Cited by 261
Memory T cell–driven differentiation of naive cells impairs adoptive immunotherapy
Klebanoff, C. A., Scott, C. D., Leonardi, A. J., Yamamoto, T. N., Cruz, A. C., Ouyang, C., Ramaswamy, M., Roychoudhuri, R., Ji, Y., Eil, R. L., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci81217 · Cited by 243
Self-citationOelke, K., Lu, Q., Richardson, D., Wu, A., Deng, C., Hanash, S., & Richardson, B. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20255 · Cited by 241
OX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T Follicular Helper Response
Jacquemin, C., Schmitt, N., Contin-Bordes, C., Liu, Y., Narayanan, P., Seneschal, J., Maurouard, T., Dougall, D., Davizon, E. S., Dumortier, H., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.05.012 · Cited by 233
TNF superfamily in inflammatory disease: translating basic insights
Croft, M., Duan, W., Choi, H., Eun, S.-Y., Madireddi, S., & Mehta, A. (2012) · Trends in Immunology · doi:10.1016/j.it.2011.10.004 · Cited by 231
Self-citationThe TNF-Family Receptor DR3 is Essential for Diverse T Cell-Mediated Inflammatory Diseases
Meylan, F., Davidson, T. S., Kahle, E., Kinder, M., Acharya, K., Jankovic, D., Bundoc, V., Hodges, M., Shevach, E. M., Keane-Myers, A., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.04.021 · Cited by 223
Self-citationGraham, D. S. C., Graham, R. R., Manku, H., Wong, A. K., Whittaker, J. C., Gaffney, P. M., Moser, K. L., Rioux, J. D., Altshuler, D., Behrens, T. W., et al. (2008) · Nature Genetics · doi:10.1038/ng.2007.47 · Cited by 222
Early, G. S., Zhao, W., & Burns, C. M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.7.3159 · Cited by 218
TL1A–DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease
Pappu, B. P., Borodovsky, A., Zheng, T. S., Yang, X., Wu, P., Dong, X., Weng, S., Browning, B., Scott, M. L., Ma, L., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071364 · Cited by 218
TWEAK/Fn14 pathway: an immunological switch for shaping tissue responses
Burkly, L. C., Michaelson, J. S., & Zheng, T. S. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01054.x · Cited by 208
Meighan-Mantha, R. L., Hsu, D. K. W., Guo, Y., Brown, S. A. N., Feng, S.-L. Y., Peifley, K. A., Alberts, G. F., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.46.33166 · Cited by 200
Jacobi, A. M., Mei, H., Hoyer, B. F., Mumtaz, I. M., Thiele, K., Radbruch, A., Burmester, G.-R., Hiepe, F., & Dörner, T. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.096495 · Cited by 188
The Cytokine TWEAK Modulates Renal Tubulointerstitial Inflammation
Sanz, A. B., Justo, P., Sanchez-Nin[Combining Tilde]o, M. D., Blanco-Colio, L. M., Winkles, J. A., Kreztler, M., Jakubowski, A., Blanco, J., Egido, J., Ruiz-Ortega, M., et al. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007050577 · Cited by 183
Costimulatory molecule-targeted antibody therapy of a spontaneous autoimmune disease
Sun, Y., Chen, H. M., Subudhi, S. K., Chen, J., Koka, R., Chen, L., & Fu, Y.-X. (2002) · Nature Medicine · doi:10.1038/nm1202-796 · Cited by 181
Fang, L., Adkins, B., Deyev, V., & Podack, E. R. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072528 · Cited by 178
Karin, M., & Gallagher, E. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00755.x · Cited by 178
Foell, J. L., Strahotin, S., O’Neil, S. P., McCausland, M. M., Suwyn, C. R., Haber, M., Chander, P. N., Bapat, A. S., Yan, X., Chiorazzi, N., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17662 · Cited by 176
Nagy, V., & Penninger, J. M. (2015) · Gerontology · doi:10.1159/000371845 · Cited by 171
Therapeutic Treg expansion in mice by TNFRSF25 prevents allergic lung inflammation
Schreiber, T. H., Wolf, D., Tsai, M. S., Chirinos, J., Deyev, V. V., Gonzalez, L., Malek, T. R., Levy, R. B., & Podack, E. R. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42933 · Cited by 165
Cutting Edge: OX40 Agonists Can Drive Regulatory T Cell Expansion if the Cytokine Milieu Is Right
Ruby, C. E., Yates, M. A., Hirschhorn-Cymerman, D., Chlebeck, P., Wolchok, J. D., Houghton, A. N., Offner, H., & Weinberg, A. D. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901112 · Cited by 164
Proinflammatory Effects of Tweak/Fn14 Interactions in Glomerular Mesangial Cells
Campbell, S., Burkly, L. C., Gao, H.-X., Berman, J. W., Su, L., Browning, B., Zheng, T., Schiffer, L., Michaelson, J. S., & Putterman, C. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1889 · Cited by 159
Schnitzer, T. J., & Marks, J. A. (2015) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2014.10.003 · Cited by 159
Davis, J. C., Totoritis, M. C., Rosenberg, J., Sklenar, T. A., & Wofsy, D. (2001) · PubMed · Cited by 146
Association of TNFSF4 (OX40L) polymorphisms with susceptibility to systemic sclerosis
Gourh, P., Arnett, F. C., Tan, F. K., Assassi, S., Divecha, D., Paz, G., McNearney, T. A., Draeger, H. T., Reveille, J. D., Mayes, M. D., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.116434 · Cited by 145
TWEAK Is a Novel Arthritogenic Mediator
Perper, S. J., Browning, B., Burkly, L. C., Weng, S., Gao, C. O., Giza, K., Su, L., Tarilonte, L., Crowell, T., Rajman, L. A., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2610 · Cited by 142
Zhao, Z., Burkly, L. C., Campbell, S., Schwartz, N., Molano, A., Choudhury, A., Eisenberg, R. A., Michaelson, J. S., & Putterman, C. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.11.7949 · Cited by 142
Denosumab for the treatment of osteoporosis
Zaheer, S., LeBoff, M. S., & Lewiecki, E. M. (2015) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2015.1000860 · Cited by 142
HVEM signalling at mucosal barriers provides host defence against pathogenic bacteria
Shui, J., Larangé, A., Kim, G., Vela, J. L., Zahner, S. P., Cheroutre, H., & Kronenberg, M. (2012) · Nature · doi:10.1038/nature11242 · Cited by 137
Gatumu, M. K., Skarstein, K., Papandile, A., Browning, J. L., Fava, R. A., & Bolstad, A. I. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2617 · Cited by 133
Meylan, F., Richard, A. C., & Siegel, R. M. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01068.x · Cited by 132
Self-citationConstitutive OX40/OX40 Ligand Interaction Induces Autoimmune-Like Diseases
Murata, K., Nose, M., Ndhlovu, L. C., Sato, T., Sugamura, K., & Ishii, N. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.8.4628 · Cited by 130
Sánchez-Paulete, A. R., Labiano, S., Rodriguez-Ruiz, M. E., Azpilikueta, A., Etxeberría, I., Bolaños, E., Lang, V., Rodríguez, M. S., Aznar, M. A., Jure‐Kunkel, M., et al. (2016) · European Journal of Immunology · doi:10.1002/eji.201445388 · Cited by 130
Regulation of TNFRSF and innate immune signalling complexes by TRAFs and cIAPs
Silke, J., & Brink, R. A. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.114 · Cited by 125
Cassatella, M. A., da Silva, G. P., Tinazzi, I., Facchetti, F., Scapini, P., Calzetti, F., Tamassia, N., Wei, P., Nardelli, B., Roschke, V. V., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.7325 · Cited by 125
T‐cell intrinsic effects of GITR and 4‐1BB during viral infection and cancer immunotherapy
Snell, L. M., Lin, G. H. Y., McPherson, A. J., Moraes, T. J., & Watts, T. H. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01063.x · Cited by 122
Horai, R., Nakajima, A., Habiro, K., Kotani, M., Nakae, S., Matsuki, T., Nambu, A., Saijo, S., Kotaki, H., Sudo, K., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20742 · Cited by 122
A Role for the Lymphotoxin/LIGHT Axis in the Pathogenesis of Murine Collagen-Induced Arthritis
Fava, R. A., Notidis, E., Hunt, J., Szanya, V., Ratcliffe, N. R., Ngam-ek, A., de Fougerolles, A. R., Sprague, A., & Browning, J. L. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.1.115 · Cited by 121
The TNF family in T cell differentiation and function – Unanswered questions and future directions
Croft, M. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.02.005 · Cited by 119
Self-citationBamias, G., Siakavellas, S. I., Stamatelopoulos, K., Chryssochoou, E., Papamichael, C. M., & Sfikakis, P. P. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.07.014 · Cited by 119
TRAIL-R2 (DR5) Mediates Apoptosis of Synovial Fibroblasts in Rheumatoid Arthritis
Ichikawa, K., Liu, W., Fleck, M., Zhang, H., Zhao, L., Ohtsuka, T., Wang, Z., Liu, D., Mountz, J. D., Ohtsuki, M., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.2.1061 · Cited by 119
Inhibition of a novel fibrogenic factor Tl1a reverses established colonic fibrosis
Shih, D. Q., Zheng, L., Zhang, X., Zhang, H., Kanazawa, Y., Ichikawa, R., Wallace, K. L., Chen, J., Pothoulakis, C., Koon, H. W., et al. (2014) · Mucosal Immunology · doi:10.1038/mi.2014.37 · Cited by 117
Feldman, M. A., Taylor, P. C., Paleolog, E. M., Brennan, F. M., & Maini, R. N. (1998) · Transplantation Proceedings · doi:10.1016/s0041-1345(98)01365-7 · Cited by 117
Therapeutic blockade of TNF in patients with SLE—Promising or crazy?
Aringer, M., & Smolen, J. S. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.05.001 · Cited by 117
Gao, H.-X., Campbell, S. R., Burkly, L. C., Jakubowski, A., Jarchum, I., Banas, B., Saleem, M. A., Mathieson, P. W., Berman, J. W., Michaelson, J. S., et al. (2009) · Cytokine · doi:10.1016/j.cyto.2008.12.001 · Cited by 116
Bull, M. J., Williams, A. S., Mecklenburgh, Z., Calder, C. J., Twohig, J. P., Elford, C., Evans, B. A. J., Rowley, T. F., Ślebioda, T. J., Taraban, V. Y., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072378 · Cited by 114
Aten, J., Roos, A., Claessen, N., Schilder-Tol, E. J. M., ten Berge, I. J. M., & Weening, J. J. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1181426 · Cited by 114
McCann, F. E., Perocheau, D. P. B., Ruspi, G., Blazek, K. D., Davies, M. L., Feldmann, M., Dean, J. L. E., Stoop, A. A., & Williams, R. O. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38755 · Cited by 110
Plasmacytoid dendritic cells regulate B-cell growth and differentiation via CD70
Shaw, J. L., Wang, Y., Ito, T., Arima, K., & Liu, Y.-J. (2010) · Blood · doi:10.1182/blood-2009-08-239145 · Cited by 110
Regulation of inflammation, autoimmunity, and infection immunity by HVEM-BTLA signaling
Shui, J.-W., Steinberg, M. W., & Kronenberg, M. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0910528 · Cited by 109
Shock, A., Burkly, L. C., Wakefield, I. D., Peters, C., Garber, E. A., Ferrant, J. L., Taylor, F. R., Su, L., Hsu, Y., Hutto, D., et al. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0757-4 · Cited by 108
Inhibition of the lymphotoxin pathway as a therapy for autoimmune disease
Browning, J. L. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00633.x · Cited by 105
Neuropsychiatric disease in murine lupus is dependent on the TWEAK/Fn14 pathway
Wen, J., Xia, Y., Stock, A. D., Michaelson, J. S., Burkly, L. C., Gulinello, M. E., & Putterman, C. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.03.002 · Cited by 103
Therapeutic Interventions Targeting CD40L (CD154) and CD40: The Opportunities and Challenges
Law, C., & Grewal, I. S. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-89520-8_2 · Cited by 102
Inhibition of the TWEAK/Fn14 pathway attenuates renal disease in nephrotoxic serum nephritis
Xia, Y., Campbell, S. R., Broder, A. R., Herlitz, L., Abadi, M. A., Wu, P., Michaelson, J. S., Burkly, L. C., & Putterman, C. (2012) · Clinical Immunology · doi:10.1016/j.clim.2012.08.008 · Cited by 102
Ucero, A. C., Benito‐Martín, A., Calvo, I. F., Santamaría, B., Blanco, J., López-Novoa, J. M., Ruiz‐Ortega, M., Egido, J., Burkly, L. C., Martínez‐Salgado, C., et al. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.05.032 · Cited by 101
Role of glucocorticoid‐induced TNF receptor family gene (GITR) in collagen‐induced arthritis
Cuzzocrea, S., Ayroldi, E., Paola, R. D., Agostini, M., Mazzon, E., Bruscoli, S., Genovese, T., Ronchetti, S., Caputi, A. P., & Riccardi, C. (2005) · The FASEB Journal · doi:10.1096/fj.04-3556com · Cited by 98
Stohl, W., Merrill, J. T., McKay, J. D., LISSE, J. R., Zhong, Z. J., Freimuth, W. W., & Genovese, M. C. (2013) · The Journal of Rheumatology · doi:10.3899/jrheum.120886 · Cited by 97
Unchecked CD70 Expression on T Cells Lowers Threshold for T Cell Activation in Rheumatoid Arthritis
Lee, W., Yang, Z., Li, G., Weyand, C. M., & Goronzy, J. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.4.2609 · Cited by 97
Liu, Z., Xu, X., Hsu, H., Tousson, A., Yang, P., Wu, Q., Liu, C., Yu, S., Zhang, H., & Mountz, J. D. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319209 · Cited by 97
van der Linden, M. P. M., Feitsma, A. L., le Cessie, S., Kern, M., Olsson, L. M., Raychaudhuri, S., Begovich, A. B., Chang, M., Catanese, J. J., Kurreeman, F. A. S., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24721 · Cited by 96
Burkly, L. C. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.02.006 · Cited by 96
The role of BAFF in the progression of rheumatoid arthritis
Wei, F., Chang, Y., & Wei, W. (2015) · Cytokine · doi:10.1016/j.cyto.2015.07.014 · Cited by 95
LIGHT (TNFSF14), a novel mediator of bone resorption, is elevated in rheumatoid arthritis
Edwards, J., Sun, S. G., Locklin, R. M., Shipman, C. M., Adamopoulos, I. E., Athanasou, N. A., & Sabokbar, A. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21821 · Cited by 95
Increased Serum Soluble OX40 in Patients with Systemic Sclerosis
Komura, K., Yoshizaki, A., Kodera, M., Iwata, Y., Ogawa, F., Shimizu, K., Wayaku, T., Yukami, T., MURATA, M., Hasegawa, M., et al. (2008) · The Journal of Rheumatology · doi:10.3899/jrheum.080120 · Cited by 92
Jiang, H., Xiao, R., Lian, X.-R., Kanekura, T., Luo, Y., Yin, Y., Zhang, G., Yang, Y., Wang, Y., Zhao, M., et al. (2012) · Clinical Immunology · doi:10.1016/j.clim.2012.01.005 · Cited by 91
Xia, Y., Herlitz, L., Gindea, S., Wen, J., Pawar, R. D., Misharin, A. V., Perlman, H., Wu, L., Wu, P., Michaelson, J. S., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014030233 · Cited by 90
Involvement of TNF-Like Weak Inducer of Apoptosis in the Pathogenesis of Collagen-Induced Arthritis
Kamata, K., Kamijo, S., Nakajima, A., Koyanagi, A., Kurosawa, H., Yagita∥, H., & Okumura, K. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.6433 · Cited by 87
Jung, H. W., Choi, S. W., Choi, J. I., & Kwon, B. S. (2004) · Experimental & Molecular Medicine · doi:10.1038/emm.2004.2 · Cited by 86
Bamias, G., Evangelou, K., Vergou, T., Tsimaratou, K., Kaltsa, G., Antoniou, C., Kotsinas, A., Kim, S., Gorgoulis, V. G., Stratigos, A., et al. (2011) · Experimental Dermatology · doi:10.1111/j.1600-0625.2011.01304.x · Cited by 85
Pharmacological modulation of GITRL/GITR system: therapeutic perspectives
Nocentini, G., Ronchetti, S., Petrillo, M. G., & Riccardi, C. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01753.x · Cited by 83
Yin, H., Zhao, M., Wu, X., Gao, F., Luo, Y., Ma, L., Liu, S., Zhang, G., Chen, J., Li, F., et al. (2010) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2010.06.011 · Cited by 83
Cordoba, F., Wieczorek, G., Audet, M., Roth, L., Schneider, M. A., Kunkler, A., Stuber, N., Erard, M., Ceci, M., Baumgartner, R., et al. (2015) · American Journal of Transplantation · doi:10.1111/ajt.13377 · Cited by 81
Zinovieva, E., Bourgain, C., Kadi, A., Letourneur, F., Izac, B., Said‐Nahal, R., Lebrun, N., Cagnard, N., Vigier, A., Jacques, S., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000528 · Cited by 80
Association of CD40 with rheumatoid arthritis confirmed in a large UK case-control study
Orozco, G., Eyre, S., Hinks, A., Ke, X., Wilson, A. G., Bax, D. E., Morgan, A. W., Emery, P., Steer, S. E., Hocking, L. J., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.109579 · Cited by 80
TL1A Both Promotes and Protects from Renal Inflammation and Injury
Al‐Lamki, R. S., Wang, J., Tolkovsky, A. M., Bradley, J. A., Griffin, J. L., Thiru, S., Wang, E. C. Y., Bolton, E. M., Wang, M., Moore, P. A., et al. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007060706 · Cited by 78
The TNF-family cytokine TL1A: from lymphocyte costimulator to disease co-conspirator
Richard, A. C., Ferdinand, J. R., Meylan, F., Hayes, E. T., Gabay, O., & Siegel, R. M. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.3ri0315-095r · Cited by 78
Self-citationSchmitz, I., Krueger, A., Baumann, S., Schulze‐Bergkamen, H., Krammer, P. H., & Kirchhoff, S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.2930 · Cited by 76
Expression of the Activation Antigen CD27 in Rheumatoid Arthritis
Tak, P. P., Hintzen, R. Q., Teunissen, J. J. M., Smeets, T., Daha, M. R., van Lier, R. A. W., Kluin, P. M., Meinders, A. E., Swaak, A. J. G., & Breedveld, F. C. (1996) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1996.0106 · Cited by 73
Contribution of the Lymphotoxin β Receptor to Liver Regeneration
Anders, R. A., Subudhi, S. K., Wang, J. H., Pfeffer, K., & Fu, Y. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.2.1295 · Cited by 73
Engineering of a Novel Anti-CD40L Domain Antibody for Treatment of Autoimmune Diseases
Xie, J., Yamniuk, A. P., Borowski, V., Kuhn, R., Susulic, V., Rex‐Rabe, S., Yang, X., Zhou, X., Zhang, Y., Gillooly, K. M., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303239 · Cited by 71
Placke, T., Kopp, H., & Salih, H. R. (2010) · Journal of Immunology Research · doi:10.1155/2010/239083 · Cited by 70
Dolff, S., Quandt, D., Wilde, B., Feldkamp, T., Hua, F., Cai, X., Specker, C., Kribben, A., Kallenberg, C. G. M., & Witzke, O. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3100 · Cited by 69
Therapeutic targeting of the BAFF/APRIL axis in systemic lupus erythematosus
Stohl, W. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.888415 · Cited by 69
Patel, M., Xu, D., Kewin, P., Choo‐Kang, B., McSharry, C. P., Thomson, N. C., & Liew, F. Y. (2005) · European Journal of Immunology · doi:10.1002/eji.200535421 · Cited by 66
Lymphotoxin-LIGHT Pathway Regulates the Interferon Signature in Rheumatoid Arthritis
Bienkowska, J. R., Allaire, N., Thai, A., Goyal, J., Plavina, T., Nirula, A., Weaver, M., Newman, C., Petri, M., Beckman, E. M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112545 · Cited by 66
Herro, R., Antunes, R. D. S., Aguilera, A. R., Tamada, K., & Croft, M. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.12.1936 · Cited by 64
Self-citationTNF inhibitors – Mechanisms of action, approved and off-label indications
Cessak, G., Kuzawińska, O., Burda, A., Lis, K., Wojnar, M., Mirowska-Guzel, D. M., & Bałkowiec-Iskra, E. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2014.05.004 · Cited by 63
Bae, E. M., Kim, W.-J., Suk, K., Kang, Y. M., Park, J.-E., Kim, W. Y., Choi, E. M., Choi, B. K., Kwon, B. S., & Lee, W. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.05.013 · Cited by 63
Defective DNA methylation and CD70 overexpression in CD4+ T cells in MRL/lpr lupus‐prone mice
Sawalha, A. H., & Jeffries, M. A. (2007) · European Journal of Immunology · doi:10.1002/eji.200636872 · Cited by 62
Elevated Soluble CD27 Levels in Serum of Patients with Systemic Lupus Erythematosus
Font, J., Pallarés, L., Martorell, J., Martínez, E., Gayà, A., Vives, J., & Ingelmo, M. (1996) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1996.0184 · Cited by 61
García, S., Liz, M., Gómez-Reino, J. J., & Conde, C. (2010) · Arthritis Research & Therapy · doi:10.1186/ar2941 · Cited by 60
Expression of CD40 and CD40 Ligand among Cell Populations within Rheumatoid Synovial Compartment
Liu, M.-F., Chao, S.-C., Wang, C., et al. (2001) · Autoimmunity · doi:10.3109/08916930109001958 · Cited by 59
Park, M., Jung, S., Yb, P., & Lee, S. (2008) · Scandinavian Journal of Rheumatology · doi:10.1080/03009740801898608 · Cited by 58
Fukasawa, C., Kawaguchi, Y., Harigai, M., Sugiura, T., Takagi, K., Kawamoto, M., Hara, M., & Kamatani, N. (2003) · European Journal of Immunology · doi:10.1002/eji.200324088 · Cited by 58
Tsakiri, N., Papadopoulos, D., Denis, M. C., Mitsikostas, D. D., & Kollias, G. A. (2011) · European Journal of Immunology · doi:10.1002/eji.201141659 · Cited by 57
Doerner, J., Wen, J., Xia, Y., Blecher, K., Schairer, D. O., Wu, L., Chalmers, S. A., Izmirly, P., Michaelson, J. S., Burkly, L. C., et al. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.124 · Cited by 57
Ferrant, J. L., Benjamin, C. D., Cutler, A. H., Kalled, S. L., Hsu, Y., Garber, E. A., Hess, D. M., Shapiro, R. I., Kenyon, N. S., Harlan, D. M., et al. (2004) · International Immunology · doi:10.1093/intimm/dxh162 · Cited by 57
Future prospects in biologic therapy for systemic lupus erythematosus
Stohl, W. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.136 · Cited by 56
Dharmapatni, A. A. S. S. K., Smith, M., Crotti, T. N., Holding, C. A., Vincent, C., Weedon, H., Zannettino, A. C. W., Zheng, T. S., Findlay, D. M., Atkins, G. J., et al. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3294 · Cited by 56
Kennedy, W. P., Campos, J. A. S., Offutt, C., Horn, P., Herman, A. E., Townsend, M. J., Tang, M. T., Grogan, J. L., Hsieh, F., & Davis, J. C. (2014) · Arthritis Research & Therapy · doi:10.1186/s13075-014-0467-3 · Cited by 53
Herro, R., Antunes, R. D. S., Aguilera, A. R., Tamada, K., & Croft, M. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.110 · Cited by 53
Self-citationCarrier, Y., Whitters, M. J., Miyashiro, J. S., LaBranche, T. P., Ramón, H. E., Benoit, S., RYAN, M. S., Keegan, S., Guay, H., Douhan, J., et al. (2012) · European Journal of Immunology · doi:10.1002/eji.201142162 · Cited by 50
Tanezumab for Patients with Osteoarthritis of the Knee: A Meta-Analysis
Kan, S.-L., Li, Y., Ning, G., Yuan, Z.-F., Chen, L., Bi, M., Sun, J.-C., & Feng, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157105 · Cited by 50
Hurdles to the introduction of new therapies for immune-mediated kidney diseases
Anders, H., Jayne, D. R. W., & Rovin, B. H. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.206 · Cited by 49
The control of tissue fibrosis by the inflammatory molecule LIGHT (TNF Superfamily member 14)
Herro, R., & Croft, M. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.12.018 · Cited by 48
Self-citationWilde, B., Dolff, S., Cai, X., Specker, C., Becker, J. U., Tötsch, M., Costabel, U., Dürig, J., Kribben, A., Tervaert, J.-W. C., et al. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn461 · Cited by 47
Yao, Q., Seol, D., Mi, Z., & Robbins, P. D. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1867 · Cited by 47
Sanga, P., Katz, N. P., Polverejan, E., Wang, S., Kelly, K. M., Häeussler, J., & Thipphawong, J. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39943 · Cited by 46
Wang, S., Shi, Y., Yang, M., Ma, J., Tian, J., Chen, J., Mao, C., Jiao, Z., Ko, K., Essien‐Baidoo, S., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.11.018 · Cited by 45
OX40L blockade is therapeutic in arthritis, despite promoting osteoclastogenesis
Findlay, E. G., Danks, L., Madden, J., Cavanagh, M., McNamee, K., McCann, F. E., Snelgrove, R. J., Shaw, S., Feldmann, M., Taylor, P. C., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321071111 · Cited by 44
Petreaca, M. L., Do, D. C., Dhall, S., Descalzo, D. L. M., Serafino, A., Lyubovitsky, J. G., Schiller, N. L., & Martins‐Green, M. M. (2012) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2012.00785.x · Cited by 42
Bamias, G., Stamatelopoulos, K. S., Zampeli, E., Protogerou, A. D., Sigala, F., Papamichael, C. M., Christopoulos, P., Kitas, G. D., & Sfikakis, P. P. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.03.002 · Cited by 42
Bae, E. Y., Kim, W.-J., Kang, Y.-M., Suk, K., Koh, E., Cha, H.-S., Ahn, K., Huh, T.-L., & Lee, W.-H. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03363.x · Cited by 42
Antigen-specific prevention of type 1 diabetes in NOD mice is ameliorated by OX40 agonist treatment
Bresson, D., Fousteri, G., Manenkova, Y., Croft, M., & von Herrath, M. (2011) · Journal of Autoimmunity · doi:10.1016/j.jaut.2011.10.001 · Cited by 41
Self-citationTWEAK-Fn14 Cytokine-Receptor Axis: A New Player of Myocardial Remodeling and Cardiac Failure
Novoyatleva, T., Sajjad, A., & Engel, F. B. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00050 · Cited by 41
Ramaswamy, M., Cruz, A. C., Cleland, S. Y., Deng, M., Price, S. M., Rao, V. K., & Siegel, R. M. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.155 · Cited by 40
Self-citationOrigins and functional basis of regulatory CD11c+CD8+ T cells
Vinay, D. S., Kim, C. H., Choi, B. K., & Kwon, B. S. (2009) · European Journal of Immunology · doi:10.1002/eji.200839057 · Cited by 39
CD134 as target for specific drug delivery to auto-aggressive CD4+T cells in adjuvant arthritis
Boot, E. P. J., Koning, G. A., Storm, G., Wagenaar-Hilbers, J. P. A., van Eden, W., Everse, L. A., & Wauben, M. H. M. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1722 · Cited by 35
Wang, X., Hu, Y., Charpentier, T., Lamarre, A., Qi, S., Wu, J., & Luo, H. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301475 · Cited by 35
Xia, L., Shen, H., Xiao, W., & Lu, J. (2010) · Cytokine · doi:10.1016/j.cyto.2010.12.003 · Cited by 34
Swaak, A. J. G., Hintzen, R. Q., Huysen, V., van den Brink, H. G., & Smeenk, J. T. (1995) · Clinical Rheumatology · doi:10.1007/bf02208342 · Cited by 34
Citores, M. J., Rua-Figueroa, I., Rodríguez‐Gallego, C., Durántez, A., García-Laorden, M. I., Rodríguez-Lozano, C., Rodríguez-Pérez, J. C., Vargas, J. A., & Pérez-Aciego, P. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.006148 · Cited by 34
Psoriatic arthritis and TNF inhibitors: advances on effectiveness and toxicity
Caso, F., Costa, L., PUENTE, A. D., & Scarpa, R. (2014) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.973398 · Cited by 34
TWEAK Promotes Osteoclastogenesis in Rheumatoid Arthritis
Park, J., Kwok, S., Lim, M.-A., Oh, H.-J., Kim, E., Jhun, J., Ju, J. H., Park, K.-S., Park, Y., Park, S., et al. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.05.027 · Cited by 32
Jin, C., Chae, S. Y., Kim, T. H., Yang, H.-K., Lee, E. Y., Song, Y. W., Jo, D., & Lee, K. C. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.159517 · Cited by 30
CD70-expressing CD4 T cells produce IFN-γ and IL-17 in rheumatoid arthritis
Park, J. K., Han, B. K., Park, J. A., Woo, Y. J., Kim, S. Y., Lee, E. Y., Lee, E. B., Chalan, P., Boots, A. M. H., & Song, Y. W. (2014) · Lara D. Veeken · doi:10.1093/rheumatology/keu171 · Cited by 28
Foell, J. L., McCausland, M. M., BURCH, J., CORRIAZZI, N., Yan, X., Suwyn, C. R., O’Neil, S. P., Hoffmann, M. K., & Mittler, R. S. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb06052.x · Cited by 26
Association of genetic polymorphisms in CD40 with susceptibility to SLE in the Korean population
Joo, Y. B., Park, B. ‐., Shin, H. D., Park, S.-Y., Kim, I., & Bae, S. (2012) · Rheumatology · doi:10.1093/rheumatology/kes339 · Cited by 26
Elevated plasma levels of TL1A in newly diagnosed systemic lupus erythematosus patients
Xu, W., Chen, D., Li, R., Ren, C.-X., & Ye, D. (2015) · Rheumatology International · doi:10.1007/s00296-015-3277-2 · Cited by 22
Richard, A. C., Peters, J. E., Lee, J. C., Vahedi, G., Schäffer, A. A., Siegel, R. M., Lyons, P. A., & Smith, K. G. C. (2016) · Genome Medicine · doi:10.1186/s13073-016-0329-5 · Cited by 21
Self-citationParadoxical effects of targeting TNF signalling in the treatment of autoimmunity
Chen, X., & Oppenheim, J. J. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.145 · Cited by 21
Audo, R., Calmon-Hamaty, F., Papon, L., Combe, B. G., Morel, J., & Hahne, M. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38806 · Cited by 20
A FAScinating Receptor in Self-Tolerance
Ramaswamy, M., & Siegel, R. M. (2007) · Immunity · doi:10.1016/j.immuni.2007.05.004 · Cited by 16
Self-citationTNF-related apoptosis-inducing ligand (TRAIL) in rheumatoid arthritis: what’s new?
Neve, A., Corrado, A., & Cantatore, F. P. (2012) · Clinical and Experimental Medicine · doi:10.1007/s10238-012-0226-1 · Cited by 16
Fava, R. A., Browning, J. L., Gatumu, M. K., Skarstein, K., & Bolstad, A.-I. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6612-4_39 · Cited by 13
Modulation of Neurotrophin Signaling by Monoclonal Antibodies
Rosenthal, A., & Lin, J. C. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-45106-5_19 · Cited by 12
Effect of CD95 on inflammatory response in rheumatoid arthritis fibroblast-like synoviocytes
Li, X., Zhang, Z., Peng, A., He, M. Y., Xu, J., Shen, S., Zhuang, J., & Huang, X. (2014) · Cellular Immunology · doi:10.1016/j.cellimm.2014.07.004 · Cited by 10
Shi, Q., Tian, X., Zhao, Y., Luo, H., Tian, Y., & Luo, A. (2011) · Rheumatology International · doi:10.1007/s00296-011-2002-z · Cited by 5
Activation of the Ras-related GTPase Rap1 by thymocyte TCR engagement and during selection
(2000) · Pure Amsterdam UMC · doi:10.1002/1521-4141(200010)30:10 · Cited by 3
Cited by
Death by TNF: a road to inflammation
van Loo, G., & Bertrand, M. J. M. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00792-3 · Cited by 926
Zhao, J. H., Stacey, D., Eriksson, N., Macdonald-Dunlop, E., Hedman, Å. K., Kalnapenkis, A., Enroth, S., Cozzetto, D., Digby-Bell, J., Marten, J., et al. (2023) · Nature Immunology · doi:10.1038/s41590-023-01588-w · Cited by 747
The TNF Family of Ligands and Receptors: Communication Modules in the Immune System and Beyond
Dostert, C., Grusdat, M., Letellier, E., & Brenner, D. (2019) · Physiological Reviews · doi:10.1152/physrev.00045.2017 · Cited by 498
Niewczas, M. A., Pavkov, M. E., Skupien, J., Smiles, A., Md Dom, Z. I., Wilson, J. M., Park, J., Nair, V., Schlafly, A., Saulnier, P.-J., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0415-5 · Cited by 432
The group 2 innate lymphoid cell ( ILC 2) regulatory network and its underlying mechanisms
Kabata, H., Moro, K., & Koyasu, S. (2018) · Immunological Reviews · doi:10.1111/imr.12706 · Cited by 293
Metadata
- Authors
- Croft, M., & Siegel, R. M.
- Venue
- Nature Reviews Rheumatology
- Published
- 2017-03-09
- Volume
- 13
- Issue
- 4
- Pages
- 217-233
- ISSN
- 1759-4790 (ISSN-L)
- 1759-4804
- OpenAlex
- W2592820806
- Cited by
- 288
- References
- 181
- FWCI
- 5.52
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.